Furthermore, levels of CSF or plasma neurofilament light chain (NfL) are strongly associated with the progression of AD, and NfL concentration in CSF can reliably predict brain atrophy and cognition in AD [53–55]. This evidence concerns the gene NEFL and Alzheimer disease.